![Chris Picardo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Picardo
Directeur/Membre du Conseil chez Modulus Therapeutics, Inc.
Postes actifs de Chris Picardo
Sociétés | Poste | Début | Fin |
---|---|---|---|
Modulus Therapeutics, Inc.
![]() Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Directeur/Membre du Conseil | - | - |
Life Science Washington | Directeur/Membre du Conseil | 11/01/2022 | - |
Historique de carrière de Chris Picardo
Formation de Chris Picardo
Williams College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Modulus Therapeutics, Inc.
![]() Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Commercial Services |
Life Science Washington |
- Bourse
- Insiders
- Chris Picardo
- Expérience